… for several AEs not currently listed in product labelling. For epcoritamab, unlabelled signals included progressive multifocal leukoenceph…
4articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Glofitamab ×
Glofitamab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Glofitamab
4 articles · page 1 of 1epcoritamabglofitamabmosunetuzumabhaemophagocytic lymphohistiocytosisprogressive multifocal leukoencephalopathydisseminated intravascular coagulationdisseminated tuberculosis
98.7%
Glofitamabautoimmune diseasesrelapsed/refractory large B-cell lymphomaB-cell lymphomas
…0 in T and B cells, respectively. In the syngeneic tumor model, Glofitamab analog treatment significantly suppressed tumor growth. Toxicit…
lisocabtagene maraleucelmosunetuzumabglofitamabaxicabtagene ciloleucelBsAbsB-cell lymphomasFLfollicular lymphomaLBCLrelapsed/refractory B-cell lymphomas+2 more
…32%). In FL, CAR-T products such as axicabtagene ciloleucel and lisocabtagene maraleucel achieve CR rates up to 94%, with median durations of remission …
teclistamabtarlatamabtalquetamabepcoritamabelranatamabglofitamabmosunetuzumabblinatumomabbsAbsautoimmune disease
…arlatamab, epcoritamab, glofitamab, mosunetuzumab, talquetamab, teclistamab, and elranatamab. Eligibility criteria were abstracted for excl…